Clinical Trials in Pennsylvania

Showing 4041-4060 of 14,036 trials

Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

NCT05964868

The objective of this study is to determine if there is a difference in post-operative pain after septorhinoplasty when long-acting liposomal bupivacaine is used for local anesthesia compared to other standard local anesthetic regimens.

RhinoplastyPain Management

Jessyka Lighthall72 participantsStarted Feb 2024

Hershey, Pennsylvania, United States

COMPLETEDPhase 265 miles

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

NCT02222155

The aim of this trial is to test the safety and efficacy of two dose regimens of the complement C5a receptor CCX168 in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Funding Source - FDA OOPD

ANCA-associated Vasculitis

Amgen42 participantsStarted Feb 2015

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +40 more locations

Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

Find Trials by Condition in Pennsylvania

BIOTRONIK Conduction System Pacing With the Solia Lead

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Low Nicotine Content Cigarettes in Vulnerable Populations: Women of Reproductive Age

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

A Study of LY3561774 in Participants With Mixed Dyslipidemia

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Angio-IMR and Cardiac MR-derived MVO in STEMI Patients

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay